Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Enhance your travels by using credit card points for exciting tours and activities. Discover how to make it happen!
28,655 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...
A disciplined four-stock plan turns $10,000 into a steady income stream, backed by steady brands and durable cash flo...
With the national debt approaching $39 trillion, Trump's push to use tariffs as a budget fix is drawing sharp skeptic...
As the Fed signals potential rate cuts, long-duration growth names with strong cash flows could re-rate. This piece f...
Starting with $1,000 doesn’t require luck or timing. This guide identifies the smartest Vanguard option for a straigh...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
The Bay Area’s luxury housing market tightens as AI-powered wealth concentrates in upscale ZIP codes. Meanwhile, more...
As 2024 tax data determine 2026 Medicare IRMAA, retirees face steeper Part B surcharges. This report explains the two...
When a company’s CFO reports a large stock sale, investors want to know what it implies. This article breaks down the...
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Microsoft stock slipped today as tech sector headwinds and a workforce headline weighed on the shares. This article b...